FACULTY OF HEALTH SCIENCES, McMaster University

Kevin's McMaster Medicine Page

 

 

Economic Evaluation

Citation:

Guide

PROS

CONS

SUM
I. Are the Results Valid?
  1. Did the analysis provide a full economic comparison of effective health care strategies?
  1. Was a broad enough view point adopted?
  2. Were all the relevant clinical strategies compared?
  1. Were the costs and consequences properly measured and valued?
  1. Was clinical effectiveness established?
  2. Were costs measured accurately?
  3. Were data on costs and consequences appropriately integrated?
3) Was appropriate allowance made for uncertainties in the analysis?
4) Are estimates of costs and consequences related to the baseline risk in the treatment population?
II. What are the Results
  1. What were the incremental costs and effects of each strategy?
  1. How much does an allowance for uncertainty change the results?
  1. Do incremental costs and effects differ between sub-groups?
III. Will the Results Help Me in My Patient Care?
  1. Are the treatment benefits worth the harms and the costs?

 
  1. Could my patients expect similar health outcomes?

 
3) Could I expect similar costs?

 

 

 

Summary:

 

 

 

Incremental cost-effectiveness (calculated if new therapy more useful and more costly)

= difference in cost between old and new therapy

difference in effect (e.g. lives saved)